Literature DB >> 28538178

Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development.

Elena Campos-Sanchez1, Nerea Deleyto-Seldas1, Veronica Dominguez2, Enrique Carrillo-de-Santa-Pau3, Kiyoe Ura4, Pedro P Rocha5, JungHyun Kim5, Arafat Aljoufi5, Anna Esteve-Codina6, Marc Dabad6, Marta Gut6, Holger Heyn6, Yasufumi Kaneda7, Keisuke Nimura7, Jane A Skok5, Maria Luisa Martinez-Frias8, Cesar Cobaleda9.   

Abstract

Immunodeficiency is one of the most important causes of mortality associated with Wolf-Hirschhorn syndrome (WHS), a severe rare disease originated by a deletion in chromosome 4p. The WHS candidate 1 (WHSC1) gene has been proposed as one of the main genes responsible for many of the alterations in WHS, but its mechanism of action is still unknown. Here, we present in vivo genetic evidence showing that Whsc1 plays an important role at several points of hematopoietic development. Particularly, our results demonstrate that both differentiation and function of Whsc1-deficient B cells are impaired at several key developmental stages due to profound molecular defects affecting B cell lineage specification, commitment, fitness, and proliferation, demonstrating a causal role for WHSC1 in the immunodeficiency of WHS patients.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell development; H3K36 methylation; Wolf-Hirschhorn syndrome; cell cycle; class-switch recombination; hematopoiesis; hematopoietic stem cells; immunodeficiency; replicative stress

Mesh:

Substances:

Year:  2017        PMID: 28538178      PMCID: PMC5510986          DOI: 10.1016/j.celrep.2017.04.069

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  38 in total

1.  The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.

Authors:  Roger Revilla-I-Domingo; Ivan Bilic; Bojan Vilagos; Hiromi Tagoh; Anja Ebert; Ido M Tamir; Leonie Smeenk; Johanna Trupke; Andreas Sommer; Markus Jaritz; Meinrad Busslinger
Journal:  EMBO J       Date:  2012-06-05       Impact factor: 11.598

Review 2.  p53 and ribosome biogenesis stress: the essentials.

Authors:  Lior Golomb; Sinisa Volarevic; Moshe Oren
Journal:  FEBS Lett       Date:  2014-04-18       Impact factor: 4.124

3.  NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

Authors:  Alex J Kuo; Peggie Cheung; Kaifu Chen; Barry M Zee; Mitomu Kioi; Josh Lauring; Yuanxin Xi; Ben Ho Park; Xiaobing Shi; Benjamin A Garcia; Wei Li; Or Gozani
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 17.970

4.  The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.

Authors:  Jotin Marango; Manabu Shimoyama; Hitomi Nishio; Julia A Meyer; Dong-Joon Min; Andres Sirulnik; Yolanda Martinez-Martinez; Marta Chesi; P Leif Bergsagel; Ming-Ming Zhou; Samuel Waxman; Boris A Leibovitch; Martin J Walsh; Jonathan D Licht
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

5.  A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.

Authors:  Keisuke Nimura; Kiyoe Ura; Hidetaka Shiratori; Masato Ikawa; Masaru Okabe; Robert J Schwartz; Yasufumi Kaneda
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

6.  Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.

Authors:  Jaclyn Andricovich; Yan Kai; Weiqun Peng; Adlen Foudi; Alexandros Tzatsos
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

7.  Antibody deficiency in Wolf-Hirschhorn syndrome.

Authors:  J Hanley-Lopez; L L Estabrooks; R Stiehm
Journal:  J Pediatr       Date:  1998-07       Impact factor: 4.406

Review 8.  Pax5: the guardian of B cell identity and function.

Authors:  César Cobaleda; Alexandra Schebesta; Alessio Delogu; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2007-05       Impact factor: 25.606

9.  SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair.

Authors:  N Kanu; E Grönroos; P Martinez; R A Burrell; X Yi Goh; J Bartkova; A Maya-Mendoza; M Mistrík; A J Rowan; H Patel; A Rabinowitz; P East; G Wilson; C R Santos; N McGranahan; S Gulati; M Gerlinger; N J Birkbak; T Joshi; L B Alexandrov; M R Stratton; T Powles; N Matthews; P A Bates; A Stewart; Z Szallasi; J Larkin; J Bartek; C Swanton
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

10.  NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.

Authors:  Verónica García-Carpizo; Jacinto Sarmentero; Bomie Han; Osvaldo Graña; Sergio Ruiz-Llorente; David G Pisano; Manuel Serrano; Harold B Brooks; Robert M Campbell; Maria J Barrero
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

View more
  11 in total

Review 1.  The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.

Authors:  Iuliia Topchu; Rajendra P Pangeni; Igor Bychkov; Sven A Miller; Evgeny Izumchenko; Jindan Yu; Erica Golemis; John Karanicolas; Yanis Boumber
Journal:  Cell Mol Life Sci       Date:  2022-05-09       Impact factor: 9.207

2.  De novo nonsense mutation in WHSC1 (NSD2) in patient with intellectual disability and dysmorphic features.

Authors:  Ekaterina R Lozier; Fedor A Konovalov; Ilya V Kanivets; Denis V Pyankov; Philip A Koshkin; Larisa S Baleva; Alla E Sipyagina; Elena N Yakusheva; Anastasiya E Kuchina; Sergey A Korostelev
Journal:  J Hum Genet       Date:  2018-05-14       Impact factor: 3.172

Review 3.  SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.

Authors:  Jianchang Yang
Journal:  Biomark Res       Date:  2018-01-03

4.  An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.

Authors:  Alok Swaroop; Jon A Oyer; Christine M Will; Xiaoxiao Huang; Wenbo Yu; Catalina Troche; Marinka Bulic; Benjamin H Durham; Qiang Jeremy Wen; John D Crispino; Alexander D MacKerell; Richard L Bennett; Neil L Kelleher; Jonathan D Licht
Journal:  Oncogene       Date:  2018-08-31       Impact factor: 9.867

5.  Do microdeletions lead to immune deficiency?

Authors:  Sait Karaman; Filiz Hazan; Semiha Bahçeci Erdem; Nesrin Gülez; Ferah Genel
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

6.  The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.

Authors:  Hiroshi Tanaka; Tomoka Igata; Kan Etoh; Tomoaki Koga; Shin-Ichiro Takebayashi; Mitsuyoshi Nakao
Journal:  Aging Cell       Date:  2020-06-22       Impact factor: 9.304

7.  Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2.

Authors:  Yu Wang; Liming Zhu; Mei Guo; Gang Sun; Kun Zhou; Wenjing Pang; Dachun Cao; Xin Tang; Xiangjun Meng
Journal:  Cell Death Discov       Date:  2021-01-19

Review 8.  SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.

Authors:  Boshu Sun; Liangliang Xu; Wenhui Bi; Wen-Bin Ou
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

9.  The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

Authors:  Charlie E Massie; Andy G Lynch; Rosalind A Eeles; Colin S Cooper; David C Wedge; Daniel S Brewer; Claudia Buhigas; Anne Y Warren; Wing-Kit Leung; Hayley C Whitaker; Hayley J Luxton; Steve Hawkins; Jonathan Kay; Adam Butler; Yaobo Xu; Dan J Woodcock; Sue Merson; Fiona M Frame; Atef Sahli; Federico Abascal; Iñigo Martincorena; G Steven Bova; Christopher S Foster; Peter Campbell; Norman J Maitland; David E Neal
Journal:  Mol Cancer       Date:  2022-09-22       Impact factor: 41.444

10.  Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.

Authors:  Paolo Zanoni; Katharina Steindl; Deepanwita Sengupta; Or Gozani; Anita Rauch; Pascal Joset; Angela Bahr; Heinrich Sticht; Mariarosaria Lang-Muritano; Conny M A van Ravenswaaij-Arts; Marwan Shinawi; Marisa Andrews; Tania Attie-Bitach; Isabelle Maystadt; Newell Belnap; Valerie Benoit; Geoffroy Delplancq; Bert B A de Vries; Sarah Grotto; Didier Lacombe; Austin Larson; Jeroen Mourmans; Katrin Õunap; Giulia Petrilli; Rolph Pfundt; Keri Ramsey; Lot Snijders Blok; Vassilis Tsatsaris; Antonio Vitobello; Laurence Faivre; Patricia G Wheeler; Marijke R Wevers; Monica Wojcik; Markus Zweier
Journal:  Genet Med       Date:  2021-05-03       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.